HIV and HCV co-infection is a unique disease condition, and medical management of such condition is difficult due to severity and systemic complications. Added with heavy alcohol drinking, risk of liver injury increases due to several pro-inflammatory responses that subsequently get involved with alcohol metabolism. Elevated levels of fatty acids have been reported both in viral infections as well as alcoholic liver disease though such investigations have not addressed the adverse event with dual viral infection of HIV and HCV along with heavy drinking. This case report of a patient with excessive alcohol drinking and first time diagnosis of HIV and HCV dual infection, elaborating concurrent alteration in Linoleic Acid (LA) levels and pro-inflammatory shift in ω-6/ω-3 ratio along with the elevations in liver injury markers. Elevated LA has been recently studied extensively for its role in alcoholic liver disease; and in the present case, we also found it to be clinically relevant to liver injury.
References
[1]
Center of Disease Control (2014) Viral Hepatitis Populations: HIV/AIDS and Viral Hepatitis. http://www.cdc.gov/hepatitis/Populations/hiv.htm
[2]
Barve, S., Kapoor, R., Moghe, A., et al. (2009) Focus on the Liver: Alcohol Use, Highly Active Antiretroviral Therapy, and Liver Disease in HIV-Infected Patients. Alc Res & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 33, 229-236.
[3]
Bani-Sadr, F., Carrat, F., Bedossa, P., et al. (2006) Hepatic Steatosis in HIV-HCV Coinfected Patients: Analysis of Risk Factors. Aids, 20, 525-531. http://dx.doi.org/10.1097/01.aids.0000210606.63138.f5
[4]
El-Zayadi, A.R. (2008) Hepatic Steatosis: A Benign Disease or a Silent Killer. World Journal of Gastroenterology, 14, 4120. http://dx.doi.org/10.3748/wjg.14.4120
[5]
Martin-Carbonero, L., Ledinghen, V., Moreno, A., et al. (2009) Liver Fibrosis in Patients with Chronic Hepatitis C and Persistently Normal Liver Enzymes: Influence of HIV Infection. Journal of Viral Hepatitis, 16, 790-795. http://dx.doi.org/10.1111/j.1365-2893.2009.01133.x
[6]
McClain, C.J., Hill, D.B., Song, Z., Deaciuc, I. and Barve, S. (2002) Monocyte Activation in Alcoholic Liver Disease. Alcohol, 27, 53-61. http://dx.doi.org/10.1016/S0741-8329(02)00212-4
[7]
Nanji, A.A. and French, S.W. (1989) Dietary Linoleic Acid Is Required for Development of Experimentally Induced Alcoholic Liver Injury. Life Sciences, 44, 223-227. http://dx.doi.org/10.1016/0024-3205(89)90599-7
[8]
Miyoshi, H., Moriya, K. and Tsutsumi, T. (2011) Pathogenesis of Lipid Metabolism Disorder in Hepatitis C: Polyunsaturated Fatty Acids Counteract Lipid Alterations Induced by the Core Protein. Journal of Hepatology, 54, 432-438. http://dx.doi.org/10.1016/j.jhep.2010.07.039
[9]
Simopoulos, A.P. (2002) The Importance of the Ratio of Omega-6/Omega-3 Essential Fatty Acids. Biomedicine & Pharmacotherapy, 56, 365-379. http://dx.doi.org/10.1016/S0753-3322(02)00253-6
[10]
Pettinati, H.M., Weiss, R.D., Miller, W.R., Donovan, D., Ernst, D.B., Rounsaville, B.J., Series, C.M. and Mattson, M.E. (2004) Medical Management Treatment Manual. A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. COMBINE Monograph Series, 2.
[11]
Simopoulos, A.P. (2008) The Omega-6/Omega-3 Fatty Acid Ratio, Genetic Variation, and Cardiovascular Disease. Asia Pacific Journal of Clinical Nutrition, 17, 131-134.
[12]
Ostapowicz, G., Watson, K.J., Locarnini, S.A. and Desmond, P.V. (1998) Role of Alcohol in the Progression of Liver Disease Caused by Hepatitis C Virus Infection. Hepatology, 27, 1730-1735. http://dx.doi.org/10.1002/hep.510270637
[13]
Johnson, S.B., Gordon, E., McClain, C., Low, G.R. and Holman, R.T. (1985) Abnormal Polyunsaturated Fatty Acid Patterns of Serum Lipids in Alcoholism and Cirrhosis: Arachidonic Acid Deficiency in Cirrhosis. Proceedings of the National Academy of Sciences, 82, 1815-1818. http://dx.doi.org/10.1073/pnas.82.6.1815
